We compared CSF NfL levels accross these disorders and studied its association with other CSF biomarkers, with the severity of cognitive impairment and with the presence of AD pathology in DLB (DLB-AD) and DS (DS-AD). This evidence concerns the gene NEFL and Dravet syndrome.